HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

IMMUNEONCO-B

3.185

+0.0250.79%

Volume:339.60K

Turnover:1.08M

Market Cap:1.37B

PE:-5.14

High:3.270

Open:3.120

Low:3.120

Close:3.160

52wk High:16.800

52wk Low:2.800

Shares:429.00M

HK Float Shares:418.00M

Volume Ratio:0.79

T/O Rate:0.08%

Dividend:- -

Dividend Rate:- -

EPS(LYR):-0.619

ROE:-40.11%

ROA:-14.74%

PB:1.87

PE(LYR):-5.14

PS:7.93

Loading ...

Overview Company News Filings

ImmuneOnco Buys Back 92,400 H-Shares for HKD 0.30 Million, Lifting Treasury Stock to 2.27 Million

Bulletin Express

IMMUNEONCO-B Announces Share Buyback on September 16, Spending HK$297,600

IMMUNEONCO-B (01541) Completes Share Buyback of 55,200 Shares on September 11

Immuneonco Biopharma Files HKEX Next-Day Disclosure Return on Share Buyback, Cancellation

ImmuneOnco Files HKEX Next-Day Disclosure Return on Share Repurchase for Treasury Shares

ImmuneOnco Reports HKD 0.16 Million Share Buy-back; Treasury Shares Rise to 2.07 Million

Bulletin Express

ImmuneOnco Biopharma Files HKEX Next-Day Disclosure Return on Share Repurchase

ImmuneOnco Nominates Dr. Liou Hsiou-Chi as Independent Non-Executive Director

IMMUNEONCO-B Advances Phase II Trial for First-Line Advanced Liver Cancer Therapy With Initial Patient Dosing Completed

ImmuneOnco Initiates Phase II Trial: First Patient Dosed with IMM2510 + IMM27M for Front-Line Advanced HCC Therapy

Bulletin Express

ImmuneOnco Doses First Patient in Phase II Trial of Imm2510-Imm27m Combo for First-Line Advanced Liver Cancer

IMMUNEONCO-B Surges Over 10% in Afternoon Trade on Strong First-Half Revenue

Hong Kong Stock Alert | IMMUNEONCO-B (01541) Surges Nearly 12% as Robust Cash Reserves and Major Clinical Milestones Drive Sentiment

IMMUNEONCO-B Reports Interim Results with RMB 25.4 Million Revenue and Key Clinical Trial Milestones

ImmuneOnco FY26 Interim Revenue Falls 33.2% to RMB 25.4 Million; R&D Expenses Drop 7.9% to RMB 154.8 Million

ImmuneOnco reaches two clinical milestones for IMC-003: first PAH patient dosed and Phase I enrolment completed

Bulletin Express

IMMUNEONCO-B (01541) Achieves Two Key Clinical Milestones in IMC-003 Development, Including First PAH Patient Dosed

ImmuneOnco Says First PAH Patient Dosed in Phase Ib/IIa Trial of IMC-003

ImmuneOnco secures FDA IND clearance for Phase Ib/II study of dual-targeting antibody IMM0306 in systemic lupus erythematosus

Bulletin Express

ImmuneOnco Wins FDA IND Clearance for Imm0306 Lupus Phase Ib/II Trial

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigerfiesta.com/stock/01541/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"01541","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"01541\",,,,,undefined,":{"symbol":"01541","market":"HK","secType":"STK","nameCN":"IMMUNEONCO-B","latestPrice":3.185,"timestamp":1789546124785,"preClose":3.16,"halted":0,"volume":339600,"delay":0,"changeRate":0.007911392405063262,"floatShares":418000000,"shares":429000000,"eps":-0.6193021103004629,"marketStatus":"Not Yet Opened","change":0.025,"latestTime":"09-16 16:08:44","open":3.12,"high":3.27,"low":3.12,"amount":1081845,"amplitude":0.047468,"askPrice":3.26,"askSize":1200,"bidPrice":3.185,"bidSize":9600,"shortable":0,"etf":0,"ttmEps":-0.6336395384011925,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1789608600000},"marketStatusCode":0,"adr":0,"listingDate":1693843200000,"exchange":"SEHK","adjPreClose":3.16,"openAndCloseTimeList":[[1789522200000,1789531200000],[1789534800000,1789545600000]],"volumeRatio":0.79331,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"01541\",,,,,undefined,":{"symbol":"01541","floatShares":418000000,"roa":"-14.74%","roe":"-40.11%","lyrEps":-0.619302,"volumeRatio":0.79331,"shares":429000000,"dividePrice":0,"high":3.27,"amplitude":0.047468,"preClose":3.16,"low":3.12,"week52Low":2.8,"pbRate":"1.87","psRate":"7.93","week52High":16.8,"institutionHeld":0,"latestPrice":3.185,"committee":0.777778,"eps":-0.6193021103004629,"divideRate":0,"volume":339600,"delay":0,"ttmEps":-0.6336395384011925,"open":3.12,"prevYearClose":5.83,"prevWeekClose":3.205,"prevMonthClose":3.71,"prevQuarterClose":3.87,"fiveDayClose":3.4,"twentyDayClose":3.31,"sixtyDayClose":3.88},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/01541\",params:#limit:5,,,undefined,":[{"date":"2026-08-26","symbol":"01541","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787707800000,"name":null,"time":"","dateTimestamp":1787673600000,"actualEps":null},{"date":"2026-03-25","symbol":"01541","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774402200000,"name":null,"time":"","dateTimestamp":1774368000000,"actualEps":null},{"date":"2025-08-26","symbol":"01541","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756171800000,"name":null,"time":"","dateTimestamp":1756137600000,"actualEps":null},{"date":"2025-03-25","symbol":"01541","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1742866200000,"name":null,"time":"Post-Mkt","dateTimestamp":1742832000000,"actualEps":null},{"market":"HK","date":"2024-08-26","symbol":"01541","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1724601600000,"reportTimeType":"post","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"01541\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"01541\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0,"buy":0,"hold":1,"sell":0,"strongSell":0,"meanLabel":"HOLD","meanPercent":1,"analysts":1,"updateTime":1697558400000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/01541\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"01541","date":"2026-09-15","current":-5.026517,"percent":0.936997,"low":-30.003263,"twenty":-16.190912,"median":-8.938844,"eighty":-5.785394,"high":-2.993766,"avg":-11.776766,"sd":6.993951,"marketCap":1357727164},"quantilePoints":[{"date":"2023-08-31","current":-17.746094,"twenty":-17.746094,"median":-17.746094,"eighty":-17.746094,"marketCap":6942262047},{"date":"2023-09-08","current":-19.116691,"twenty":-19.083294,"median":-18.655615,"eighty":-17.801139,"marketCap":7390149921},{"date":"2023-09-15","current":-24.765877,"twenty":-24.765877,"median":-19.116691,"eighty":-18.557812,"marketCap":9648251285},{"date":"2023-09-22","current":-25.548224,"twenty":-25.200205,"median":-24.360534,"eighty":-18.753419,"marketCap":9909519212},{"date":"2023-09-29","current":-29.804324,"twenty":-26.447668,"median":-24.870232,"eighty":-19.083294,"marketCap":11580180660},{"date":"2023-10-06","current":-24.76052,"twenty":-26.458287,"median":-24.870232,"eighty":-19.110012,"marketCap":9615852761},{"date":"2023-10-13","current":-27.113287,"twenty":-26.458287,"median":-25.206314,"eighty":-22.322253,"marketCap":10513831229},{"date":"2023-10-20","current":-26.768577,"twenty":-26.795293,"median":-25.37532,"eighty":-23.788881,"marketCap":10364168151},{"date":"2023-10-27","current":-28.665306,"twenty":-27.124745,"median":-25.753577,"eighty":-24.00727,"marketCap":11093775656},{"date":"2023-11-03","current":-26.275244,"twenty":-27.500238,"median":-26.158488,"eighty":-24.473108,"marketCap":10195797188},{"date":"2023-11-10","current":-26.039628,"twenty":-27.37617,"median":-26.041732,"eighty":-24.763734,"marketCap":10102257765},{"date":"2023-11-17","current":-26.714897,"twenty":-27.225983,"median":-26.171076,"eighty":-24.792429,"marketCap":10457707575},{"date":"2023-11-24","current":-27.539565,"twenty":-27.37617,"median":-26.271304,"eighty":-24.846191,"marketCap":10869281039},{"date":"2023-12-01","current":-28.464343,"twenty":-27.564693,"median":-26.306056,"eighty":-24.874164,"marketCap":11280854504},{"date":"2023-12-08","current":-27.67933,"twenty":-27.70336,"median":-26.447668,"eighty":-25.070837,"marketCap":10925404694},{"date":"2023-12-15","current":-27.708906,"twenty":-27.817253,"median":-26.526325,"eighty":-25.207536,"marketCap":11000236233},{"date":"2023-12-22","current":-27.916049,"twenty":-27.937914,"median":-26.714897,"eighty":-25.244891,"marketCap":11075067772},{"date":"2023-12-29","current":-28.049426,"twenty":-27.986303,"median":-26.835368,"eighty":-25.288293,"marketCap":11187315080},{"date":"2024-01-05","current":-23.146888,"twenty":-27.970711,"median":-26.68937,"eighty":-25.200205,"marketCap":9166863527},{"date":"2024-01-12","current":-26.439512,"twenty":-27.935571,"median":-26.500765,"eighty":-25.200205,"marketCap":10476415460},{"date":"2024-01-19","current":-25.435754,"twenty":-27.916049,"median":-26.490281,"eighty":-25.212424,"marketCap":10064841995},{"date":"2024-01-26","current":-23.636611,"twenty":-27.83997,"median":-26.442842,"eighty":-24.972615,"marketCap":9316526605},{"date":"2024-02-02","current":-21.195554,"twenty":-27.817533,"median":-26.372788,"eighty":-24.783518,"marketCap":8343716598},{"date":"2024-02-09","current":-18.727145,"twenty":-27.802108,"median":-26.275244,"eighty":-24.041989,"marketCap":7408322361},{"date":"2024-02-16","current":-17.739662,"twenty":-27.801452,"median":-26.252628,"eighty":-23.794995,"marketCap":7019198358},{"date":"2024-02-23","current":-22.387155,"twenty":-27.764049,"median":-26.165159,"eighty":-23.13759,"marketCap":8811413717},{"date":"2024-03-01","current":-17.708555,"twenty":-27.735275,"median":-26.04068,"eighty":-22.460898,"marketCap":6974299434},{"date":"2024-03-08","current":-19.229551,"twenty":-27.718352,"median":-26.025076,"eighty":-21.141323,"marketCap":7576693323},{"date":"2024-03-15","current":-16.157629,"twenty":-27.69116,"median":-25.695795,"eighty":-19.998834,"marketCap":6360680815},{"date":"2024-03-22","current":-15.411367,"twenty":-27.66021,"median":-25.548224,"eighty":-19.057216,"marketCap":6061354659},{"date":"2024-03-28","current":-14.696214,"twenty":-27.629432,"median":-25.408294,"eighty":-18.737655,"marketCap":6038905197},{"date":"2024-04-05","current":-13.011166,"twenty":-27.602384,"median":-25.364375,"eighty":-18.557812,"marketCap":5342971884},{"date":"2024-04-12","current":-13.094845,"twenty":-27.539565,"median":-25.225009,"eighty":-18.239836,"marketCap":5380387654},{"date":"2024-04-19","current":-13.014894,"twenty":-27.51439,"median":-25.154554,"eighty":-17.708555,"marketCap":5342971884},{"date":"2024-04-26","current":-13.779237,"twenty":-27.443648,"median":-24.972615,"eighty":-16.602696,"marketCap":5649781194},{"date":"2024-05-03","current":-12.839078,"twenty":-27.434442,"median":-24.870232,"eighty":-16.184677,"marketCap":5260657191},{"date":"2024-05-10","current":-13.282389,"twenty":-27.357513,"median":-24.774698,"eighty":-14.702373,"marketCap":5455219193},{"date":"2024-05-17","current":-13.228926,"twenty":-27.225983,"median":-24.581805,"eighty":-14.243189,"marketCap":5425286577},{"date":"2024-05-24","current":-13.350651,"twenty":-27.145452,"median":-23.955191,"eighty":-13.966896,"marketCap":5462702347},{"date":"2024-05-31","current":-13.410156,"twenty":-27.124745,"median":-23.750163,"eighty":-13.747349,"marketCap":5492634962},{"date":"2024-06-07","current":-14.158514,"twenty":-27.039336,"median":-23.288627,"eighty":-13.645876,"marketCap":5791961118},{"date":"2024-06-14","current":-13.347574,"twenty":-26.971042,"median":-23.123643,"eighty":-13.527845,"marketCap":5455219193},{"date":"2024-06-21","current":-13.283836,"twenty":-26.926395,"median":-22.448608,"eighty":-13.452996,"marketCap":5417803423},{"date":"2024-06-28","current":-12.683619,"twenty":-26.848726,"median":-21.974147,"eighty":-13.40419,"marketCap":5170859344},{"date":"2024-07-05","current":-11.291057,"twenty":-26.759122,"median":-21.059976,"eighty":-13.359292,"marketCap":4602139648},{"date":"2024-07-12","current":-12.246119,"twenty":-26.720023,"median":-20.206581,"eighty":-13.323498,"marketCap":4998746805},{"date":"2024-07-19","current":-11.915911,"twenty":-26.704686,"median":-19.229551,"eighty":-13.282563,"marketCap":4864050035},{"date":"2024-07-26","current":-11.780484,"twenty":-26.652155,"median":-19.050696,"eighty":-13.224977,"marketCap":4826634265},{"date":"2024-08-02","current":-13.633124,"twenty":-26.594701,"median":-18.753419,"eighty":-13.20236,"marketCap":5582432809},{"date":"2024-08-09","current":-9.567144,"twenty":-26.54166,"median":-18.630761,"eighty":-13.102374,"marketCap":3943622105},{"date":"2024-08-16","current":-8.483685,"twenty":-26.496571,"median":-18.451463,"eighty":-13.086665,"marketCap":3498374448},{"date":"2024-08-23","current":-8.095604,"twenty":-26.47337,"median":-18.020488,"eighty":-13.035717,"marketCap":3352452947},{"date":"2024-08-30","current":-7.377309,"twenty":-26.446703,"median":-17.739662,"eighty":-12.990136,"marketCap":3034418906},{"date":"2024-09-06","current":-4.227864,"twenty":-26.442176,"median":-17.681919,"eighty":-12.840212,"marketCap":1739833281},{"date":"2024-09-13","current":-4.503325,"twenty":-26.43833,"median":-16.602696,"eighty":-12.741292,"marketCap":1848339013},{"date":"2024-09-20","current":-4.539912,"twenty":-26.433601,"median":-16.202037,"eighty":-12.246119,"marketCap":1874530051},{"date":"2024-09-27","current":-5.476578,"twenty":-26.311976,"median":-15.844451,"eighty":-11.915911,"marketCap":2274878785},{"date":"2024-10-04","current":-6.596451,"twenty":-26.302504,"median":-15.05764,"eighty":-11.832338,"marketCap":2727609596},{"date":"2024-10-10","current":-5.983695,"twenty":-26.285201,"median":-14.496802,"eighty":-11.807116,"marketCap":2458216056},{"date":"2024-10-18","current":-5.191078,"twenty":-26.27288,"median":-14.209972,"eighty":-11.719903,"marketCap":2121474130},{"date":"2024-10-25","current":-7.104995,"twenty":-26.248892,"median":-14.119017,"eighty":-11.287262,"marketCap":2903463713},{"date":"2024-11-01","current":-6.615271,"twenty":-26.199776,"median":-13.881638,"eighty":-9.764235,"marketCap":2705160134},{"date":"2024-11-08","current":-6.847628,"twenty":-26.169892,"median":-13.803075,"eighty":-8.441853,"marketCap":2787474827},{"date":"2024-11-15","current":-7.078843,"twenty":-26.118271,"median":-13.690467,"eighty":-8.248986,"marketCap":2851081635},{"date":"2024-11-22","current":-6.784782,"twenty":-26.059844,"median":-13.633178,"eighty":-7.853303,"marketCap":2731351173},{"date":"2024-11-29","current":-5.682581,"twenty":-26.04047,"median":-13.539989,"eighty":-7.45767,"marketCap":2286103516},{"date":"2024-12-06","current":-5.602773,"twenty":-26.037499,"median":-13.514674,"eighty":-7.358253,"marketCap":2248687746},{"date":"2024-12-13","current":-6.121403,"twenty":-26.029477,"median":-13.45004,"eighty":-7.218028,"marketCap":2451992323},{"date":"2024-12-20","current":-5.137492,"twenty":-25.962318,"median":-13.411134,"eighty":-7.087735,"marketCap":2048757705},{"date":"2024-12-27","current":-4.957491,"twenty":-25.887099,"median":-13.400213,"eighty":-7.078006,"marketCap":1975442320},{"date":"2025-01-03","current":-5.238569,"twenty":-25.753577,"median":-13.368079,"eighty":-6.925822,"marketCap":2089488475},{"date":"2025-01-10","current":-5.002231,"twenty":-25.638014,"median":-13.3526,"eighty":-6.765934,"marketCap":1987661551},{"date":"2025-01-17","current":-5.018682,"twenty":-25.5579,"median":-13.317479,"eighty":-6.665777,"marketCap":1995807705},{"date":"2025-01-24","current":-5.323319,"twenty":-25.548224,"median":-13.283546,"eighty":-6.596451,"marketCap":2130219244},{"date":"2025-01-28","current":-5.224689,"twenty":-25.503236,"median":-13.282823,"eighty":-6.532117,"marketCap":2101707706},{"date":"2025-02-07","current":-5.549725,"twenty":-25.42477,"median":-13.246663,"eighty":-6.254752,"marketCap":2219826937},{"date":"2025-02-14","current":-5.930475,"twenty":-25.395104,"median":-13.220128,"eighty":-6.076947,"marketCap":2366457707},{"date":"2025-02-21","current":-6.375256,"twenty":-25.366564,"median":-13.201126,"eighty":-6.054191,"marketCap":2557892324},{"date":"2025-02-28","current":-5.632443,"twenty":-25.318672,"median":-13.116805,"eighty":-5.974648,"marketCap":2252411553},{"date":"2025-03-07","current":-5.782376,"twenty":-25.249925,"median":-13.099044,"eighty":-5.827424,"marketCap":2321653861},{"date":"2025-03-14","current":-4.421401,"twenty":-25.219975,"median":-13.087912,"eighty":-5.725677,"marketCap":1775861550},{"date":"2025-03-21","current":-4.778207,"twenty":-25.207536,"median":-13.071662,"eighty":-5.66584,"marketCap":1918419243},{"date":"2025-03-28","current":-6.735516,"twenty":-25.163684,"median":-13.026305,"eighty":-5.651503,"marketCap":2276850015},{"date":"2025-04-03","current":-7.956153,"twenty":-25.0977,"median":-13.01303,"eighty":-5.66026,"marketCap":2684157710},{"date":"2025-04-11","current":-6.344288,"twenty":-25.036833,"median":-12.972072,"eighty":-5.68428,"marketCap":2126146167},{"date":"2025-04-17","current":-6.122985,"twenty":-24.972615,"median":-12.844749,"eighty":-5.691075,"marketCap":2056903859},{"date":"2025-04-25","current":-8.576896,"twenty":-24.895951,"median":-12.836736,"eighty":-5.703559,"marketCap":2883738480},{"date":"2025-05-02","current":-7.700417,"twenty":-24.872853,"median":-12.82514,"eighty":-5.710649,"marketCap":2594550017},{"date":"2025-05-09","current":-7.730765,"twenty":-24.846191,"median":-12.683619,"eighty":-5.725677,"marketCap":2623061555},{"date":"2025-05-16","current":-8.311097,"twenty":-24.799485,"median":-12.12195,"eighty":-5.751942,"marketCap":2843007711},{"date":"2025-05-23","current":-11.289802,"twenty":-24.776462,"median":-11.940532,"eighty":-5.771038,"marketCap":3873496179},{"date":"2025-05-30","current":-15.223569,"twenty":-24.763734,"median":-11.970101,"eighty":-5.797425,"marketCap":5246123111},{"date":"2025-06-06","current":-16.623143,"twenty":-24.617548,"median":-12.331836,"eighty":-5.827424,"marketCap":5743038499},{"date":"2025-06-13","current":-15.603079,"twenty":-24.258649,"median":-12.701975,"eighty":-5.862056,"marketCap":5392753881},{"date":"2025-06-20","current":-14.878015,"twenty":-24.00727,"median":-12.82804,"eighty":-5.90109,"marketCap":5132076957},{"date":"2025-06-27","current":-13.023121,"twenty":-23.933348,"median":-12.837907,"eighty":-5.91626,"marketCap":4504823106},{"date":"2025-07-04","current":-14.906416,"twenty":-23.89321,"median":-12.895238,"eighty":-5.935244,"marketCap":5156515418},{"date":"2025-07-11","current":-12.022018,"twenty":-23.818294,"median":-12.972072,"eighty":-5.957179,"marketCap":4154538489},{"date":"2025-07-18","current":-12.975089,"twenty":-23.597552,"median":-12.895238,"eighty":-5.971632,"marketCap":4480384645},{"date":"2025-07-25","current":-12.316929,"twenty":-23.410778,"median":-12.839078,"eighty":-5.984465,"marketCap":4268584643},{"date":"2025-08-01","current":-12.109688,"twenty":-23.260279,"median":-12.895238,"eighty":-5.992729,"marketCap":4170830796},{"date":"2025-08-08","current":-13.046774,"twenty":-23.142239,"median":-12.972072,"eighty":-6.013995,"marketCap":4504823106},{"date":"2025-08-15","current":-15.594562,"twenty":-23.052783,"median":-12.982136,"eighty":-6.023266,"marketCap":5376461574},{"date":"2025-08-22","current":-14.245172,"twenty":-22.717488,"median":-13.011166,"eighty":-6.052989,"marketCap":4895838493},{"date":"2025-08-29","current":-13.416028,"twenty":-22.485479,"median":-13.022379,"eighty":-6.061027,"marketCap":4439653875},{"date":"2025-09-05","current":-17.224047,"twenty":-22.314693,"median":-13.032106,"eighty":-6.075447,"marketCap":5694161576},{"date":"2025-09-12","current":-15.065483,"twenty":-22.014704,"median":-13.063177,"eighty":-6.087386,"marketCap":4989519263},{"date":"2025-09-19","current":-14.903882,"twenty":-21.818428,"median":-13.085834,"eighty":-6.113201,"marketCap":4932496186},{"date":"2025-09-26","current":-13.980202,"twenty":-21.168438,"median":-13.096763,"eighty":-6.121719,"marketCap":4614796184},{"date":"2025-10-03","current":-19.067762,"twenty":-21.059976,"median":-13.099741,"eighty":-6.122985,"marketCap":6309196195},{"date":"2025-10-10","current":-15.483575,"twenty":-20.658991,"median":-13.109708,"eighty":-6.128239,"marketCap":5115784649},{"date":"2025-10-17","current":-12.892469,"twenty":-20.520951,"median":-13.123492,"eighty":-6.17051,"marketCap":4256365412},{"date":"2025-10-24","current":-11.824326,"twenty":-20.411262,"median":-13.104868,"eighty":-6.183537,"marketCap":3905144639},{"date":"2025-10-31","current":-11.96327,"twenty":-20.170656,"median":-13.098863,"eighty":-6.223751,"marketCap":3956925563},{"date":"2025-11-07","current":-10.312858,"twenty":-19.984772,"median":-13.08999,"eighty":-6.257081,"marketCap":3408910790},{"date":"2025-11-14","current":-10.296734,"twenty":-19.520389,"median":-13.071805,"eighty":-6.311268,"marketCap":3413225867},{"date":"2025-11-21","current":-8.92105,"twenty":-19.161835,"median":-13.046774,"eighty":-6.362869,"marketCap":2955827710},{"date":"2025-11-28","current":-9.407815,"twenty":-19.096653,"median":-13.027047,"eighty":-6.414675,"marketCap":3128430788},{"date":"2025-12-05","current":-8.666243,"twenty":-19.073975,"median":-13.014894,"eighty":-6.44644,"marketCap":2886786479},{"date":"2025-12-12","current":-8.404571,"twenty":-19.037964,"median":-12.986335,"eighty":-6.450097,"marketCap":2804800017},{"date":"2025-12-19","current":-8.049417,"twenty":-18.988805,"median":-12.975089,"eighty":-6.476679,"marketCap":2692608016},{"date":"2025-12-24","current":-7.972984,"twenty":-18.926105,"median":-12.9589,"eighty":-6.505915,"marketCap":2675347709},{"date":"2026-01-02","current":-7.788017,"twenty":-18.753419,"median":-12.908879,"eighty":-6.55197,"marketCap":2623566785},{"date":"2026-01-09","current":-8.075331,"twenty":-18.727145,"median":-12.839078,"eighty":-6.58869,"marketCap":2727128632},{"date":"2026-01-16","current":-7.93455,"twenty":-18.70371,"median":-12.833897,"eighty":-6.596451,"marketCap":2688292939},{"date":"2026-01-23","current":-6.093671,"twenty":-18.557812,"median":-12.82514,"eighty":-6.55197,"marketCap":2062606782},{"date":"2026-01-30","current":-5.748685,"twenty":-18.530718,"median":-12.736832,"eighty":-6.440954,"marketCap":1954729858},{"date":"2026-02-06","current":-5.480977,"twenty":-18.467104,"median":-12.547098,"eighty":-6.250095,"marketCap":1868428319},{"date":"2026-02-13","current":-5.764322,"twenty":-18.451463,"median":-12.334661,"eighty":-6.129552,"marketCap":1976305243},{"date":"2026-02-20","current":-5.709616,"twenty":-18.447248,"median":-12.324382,"eighty":-6.122036,"marketCap":1954729858},{"date":"2026-02-27","current":-5.173921,"twenty":-18.36049,"median":-12.246119,"eighty":-6.086335,"marketCap":1790756934},{"date":"2026-03-06","current":-5.567891,"twenty":-18.158064,"median":-12.065853,"eighty":-6.054191,"marketCap":1911579088},{"date":"2026-03-13","current":-6.117869,"twenty":-18.015354,"median":-11.997781,"eighty":-6.054191,"marketCap":2110072628},{"date":"2026-03-20","current":-5.927628,"twenty":-17.916043,"median":-11.941476,"eighty":-6.046952,"marketCap":2036716320},{"date":"2026-03-27","current":-7.775976,"twenty":-17.807771,"median":-11.897801,"eighty":-5.998519,"marketCap":1924524319},{"date":"2026-04-02","current":-8.241979,"twenty":-17.7975,"median":-11.83436,"eighty":-6.013995,"marketCap":2049661551},{"date":"2026-04-10","current":-8.161679,"twenty":-17.786583,"median":-11.824288,"eighty":-6.015601,"marketCap":2045346474},{"date":"2026-04-17","current":-10.223634,"twenty":-17.753464,"median":-11.822864,"eighty":-6.03821,"marketCap":2563155708},{"date":"2026-04-24","current":-8.708527,"twenty":-17.740948,"median":-11.788146,"eighty":-6.050175,"marketCap":2183428936},{"date":"2026-04-30","current":-8.01805,"twenty":-17.720998,"median":-11.771721,"eighty":-6.055393,"marketCap":2010825858},{"date":"2026-05-08","current":-7.201573,"twenty":-17.693999,"median":-11.728007,"eighty":-6.067488,"marketCap":1812332319},{"date":"2026-05-15","current":-6.019771,"twenty":-17.681444,"median":-11.664585,"eighty":-6.067488,"marketCap":1518907086},{"date":"2026-05-22","current":-5.845011,"twenty":-17.559701,"median":-11.603261,"eighty":-6.055393,"marketCap":1471441239},{"date":"2026-05-29","current":-5.00485,"twenty":-17.377503,"median":-11.514742,"eighty":-6.021369,"marketCap":1264317546},{"date":"2026-06-05","current":-5.406956,"twenty":-17.219881,"median":-11.323354,"eighty":-5.987951,"marketCap":1367879393},{"date":"2026-06-12","current":-6.161616,"twenty":-17.185737,"median":-11.281569,"eighty":-5.974648,"marketCap":1557742778},{"date":"2026-06-18","current":-6.148633,"twenty":-17.12503,"median":-11.173523,"eighty":-5.983773,"marketCap":1557742778},{"date":"2026-06-26","current":-6.245478,"twenty":-17.024379,"median":-10.700224,"eighty":-5.984776,"marketCap":1575003086},{"date":"2026-07-03","current":-6.68536,"twenty":-16.923645,"median":-10.487176,"eighty":-5.987546,"marketCap":1687195087},{"date":"2026-07-10","current":-5.923214,"twenty":-16.909148,"median":-10.312858,"eighty":-5.984083,"marketCap":1493016624},{"date":"2026-07-17","current":-5.902209,"twenty":-16.682476,"median":-10.158539,"eighty":-5.968616,"marketCap":1493016624},{"date":"2026-07-24","current":-5.542738,"twenty":-16.623143,"median":-9.958283,"eighty":-5.926348,"marketCap":1402400008},{"date":"2026-07-31","current":-5.106671,"twenty":-16.606785,"median":-9.895629,"eighty":-5.905868,"marketCap":1294523085},{"date":"2026-08-07","current":-5.351615,"twenty":-16.539438,"median":-9.757608,"eighty":-5.872434,"marketCap":1359249239},{"date":"2026-08-14","current":-6.61743,"twenty":-16.502556,"median":-9.567144,"eighty":-5.872434,"marketCap":1682880010},{"date":"2026-08-21","current":-5.73939,"twenty":-16.475236,"median":-9.478992,"eighty":-5.870008,"marketCap":1462811086},{"date":"2026-08-28","current":-5.937689,"twenty":-16.271167,"median":-9.407815,"eighty":-5.870008,"marketCap":1594040436},{"date":"2026-09-04","current":-5.439364,"twenty":-16.205935,"median":-9.267733,"eighty":-5.847482,"marketCap":1460845683},{"date":"2026-09-11","current":-5.120491,"twenty":-16.193559,"median":-9.001174,"eighty":-5.799572,"marketCap":1377061886},{"date":"2026-09-15","current":-5.049418,"twenty":-16.190912,"median":-8.938844,"eighty":-5.785394,"marketCap":1357727164}],"updateTime":1789586214510},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"01541\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1156750724","title":"ImmuneOnco Buys Back 92,400 H-Shares for HKD 0.30 Million, Lifting Treasury Stock to 2.27 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1156750724","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1156750724?lang=en_us&edition=fundamental","pubTime":"2026-09-16 19:03","pubTimestamp":1789556610,"startTime":"0","endTime":"0","summary":"ImmuneOnco Biopharmaceuticals (Shanghai) Inc. repurchased 92,400 H-shares on the Hong Kong Stock Exchange on 16 September 2026, paying an aggregate HKD 0.30 million at prices ranging from HKD 3.155...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01541"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1122307656","title":"IMMUNEONCO-B Announces Share Buyback on September 16, Spending HK$297,600","url":"https://stock-news.laohu8.com/highlight/detail?id=1122307656","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1122307656?lang=en_us&edition=fundamental","pubTime":"2026-09-16 18:52","pubTimestamp":1789555945,"startTime":"0","endTime":"0","summary":"IMMUNEONCO-B (01541) disclosed on September 16 that it repurchased 92,400 of its own shares on the same day.The buyback was executed at a total cost of HK$297,600, with each share priced between HK$3.155 and HK$3.27 during the transaction.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","01541"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1180962518","title":"IMMUNEONCO-B (01541) Completes Share Buyback of 55,200 Shares on September 11","url":"https://stock-news.laohu8.com/highlight/detail?id=1180962518","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1180962518?lang=en_us&edition=fundamental","pubTime":"2026-09-11 18:28","pubTimestamp":1789122500,"startTime":"0","endTime":"0","summary":"IMMUNEONCO-B (01541) has announced that on September 11, 2026, the company repurchased 55,200 of its shares for a total consideration of HK$177,600.The buyback transaction was disclosed in an official filing, reflecting the company's ongoing capital management strategy.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01541","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666525732","title":"Immuneonco Biopharma Files HKEX Next-Day Disclosure Return on Share Buyback, Cancellation","url":"https://stock-news.laohu8.com/highlight/detail?id=2666525732","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666525732?lang=en_us&edition=fundamental","pubTime":"2026-09-11 18:26","pubTimestamp":1789122399,"startTime":"0","endTime":"0","summary":"Immuneonco Biopharma files HKEX next-day disclosure return on share buyback, cancellationImmuneonco Biopharmaceuticals filed a next-day disclosure return showing a repurchase of 55,200 H shares on Sep","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260911:nNDL8qrm3p:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01541","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666562554","title":"ImmuneOnco Files HKEX Next-Day Disclosure Return on Share Repurchase for Treasury Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2666562554","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666562554?lang=en_us&edition=fundamental","pubTime":"2026-09-10 18:14","pubTimestamp":1789035243,"startTime":"0","endTime":"0","summary":"ImmuneOnco files HKEX next-day disclosure return on share repurchase for treasury sharesImmuneOnco repurchased 58,000 H shares on Sept. 10 for treasury.Buyback price ranged from HKD 3.35 to HKD 3.44 p","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nNDL6PWdxv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01541","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1145259717","title":"ImmuneOnco Reports HKD 0.16 Million Share Buy-back; Treasury Shares Rise to 2.07 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1145259717","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1145259717?lang=en_us&edition=fundamental","pubTime":"2026-09-04 18:41","pubTimestamp":1788518510,"startTime":"0","endTime":"0","summary":"ImmuneOnco Biopharmaceuticals (Shanghai) Inc. disclosed a new share repurchase on 4 September 2026 under its existing mandate, buying back 44,800 H shares on the Hong Kong Stock Exchange. Key...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01541"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664336510","title":"ImmuneOnco Biopharma Files HKEX Next-Day Disclosure Return on Share Repurchase","url":"https://stock-news.laohu8.com/highlight/detail?id=2664336510","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664336510?lang=en_us&edition=fundamental","pubTime":"2026-09-04 18:39","pubTimestamp":1788518380,"startTime":"0","endTime":"0","summary":"ImmuneOnco Biopharma files HKEX next-day disclosure return on share repurchaseImmuneOnco Biopharmaceuticals (Shanghai) filed a next-day disclosure return reporting a 44,800 H-share buyback on Sept. 4.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260904:nNDLc9gB6h:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01541","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662909679","title":"ImmuneOnco Nominates Dr. Liou Hsiou-Chi as Independent Non-Executive Director","url":"https://stock-news.laohu8.com/highlight/detail?id=2662909679","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662909679?lang=en_us&edition=fundamental","pubTime":"2026-08-28 22:01","pubTimestamp":1787925691,"startTime":"0","endTime":"0","summary":"ImmuneOnco nominates Dr. Liou Hsiou-Chi as independent non-executive directorImmuneOnco Biopharmaceuticals (Shanghai) disclosed the planned exit of independent director Zhenping Zhu, effective once a ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nNDL2q61tP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0130103400.USD","FNCL","LU0640476718.USD","LU0106831901.USD","FTXO","LU0683600562.USD","LU0130102774.USD","LU0130517989.USD","LU0306807586.USD","LU0052756011.USD","UYG","LU0320765489.SGD","BK4588","BK4534","TFNS","BK4504","LU0868494617.USD","LU1366192091.USD","LU2133065610.SGD","IE00BLSP4452.SGD","LU1162221912.USD","LU0098860793.USD","IE00B1BXHZ80.USD","LU0208291251.USD","LU0648001328.SGD","VFH","LU0234572021.USD","LU0128525689.USD","IE0002270589.USD","LU0053666078.USD","01541","BK4553","LU1291159041.SGD","IYG","LU1280957306.USD","LU1804176565.USD","LU1880398554.USD","LU0980610538.SGD","LU1201861249.SGD","LU1989771016.USD","XLF","IYF","IE0001KFT4U8.USD","LU0130518102.USD","LU1883839398.USD","BAC","KBWB","LU1894683264.USD","LU0070302665.USD","LU0321505868.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1195720547","title":"IMMUNEONCO-B Advances Phase II Trial for First-Line Advanced Liver Cancer Therapy With Initial Patient Dosing Completed","url":"https://stock-news.laohu8.com/highlight/detail?id=1195720547","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1195720547?lang=en_us&edition=fundamental","pubTime":"2026-08-27 21:24","pubTimestamp":1787837055,"startTime":"0","endTime":"0","summary":"IMMUNEONCO-B (01541) has announced that the Phase II clinical trial evaluating IMM2510 (Peravrafusp alfa) in combination with IMM27M (Tazebsumab) as a first-line treatment for patients with advanced...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MDTX","BK4006","HCC","BK1161","PSYK","BMED","IBBJ","01541","COAL","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1194851355","title":"ImmuneOnco Initiates Phase II Trial: First Patient Dosed with IMM2510 + IMM27M for Front-Line Advanced HCC Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=1194851355","media":"Bulletin Express","labels":["productRelease","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1194851355?lang=en_us&edition=fundamental","pubTime":"2026-08-27 21:21","pubTimestamp":1787836918,"startTime":"0","endTime":"0","summary":"ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (IMMUNEONCO-B, 01541) has dosed the first patient in its Phase II study evaluating the combination of IMM2510 (palverafusp alfa) and IMM27M...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01541"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662108812","title":"ImmuneOnco Doses First Patient in Phase II Trial of Imm2510-Imm27m Combo for First-Line Advanced Liver Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2662108812","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662108812?lang=en_us&edition=fundamental","pubTime":"2026-08-27 21:21","pubTimestamp":1787836874,"startTime":"0","endTime":"0","summary":"ImmuneOnco doses first patient in Phase II trial of IMM2510-IMM27M combo for first-line advanced liver cancerImmuneOnco dosed the first patient in a Phase II study of IMM2510 with IMM27M as first-line","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nNDLbNw7m4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01541","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1166965470","title":"IMMUNEONCO-B Surges Over 10% in Afternoon Trade on Strong First-Half Revenue","url":"https://stock-news.laohu8.com/highlight/detail?id=1166965470","media":"Deep News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1166965470?lang=en_us&edition=fundamental","pubTime":"2026-08-27 13:51","pubTimestamp":1787809861,"startTime":"0","endTime":"0","summary":"Shares of IMMUNEONCO-B (01541) rallied sharply during Tuesday afternoon trading, climbing nearly 12% at one point before settling at a 10.27% gain to HK$4.08, with turnover reaching HK$6.239 million....","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","01541"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1187887739","title":"Hong Kong Stock Alert | IMMUNEONCO-B (01541) Surges Nearly 12% as Robust Cash Reserves and Major Clinical Milestones Drive Sentiment","url":"https://stock-news.laohu8.com/highlight/detail?id=1187887739","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1187887739?lang=en_us&edition=fundamental","pubTime":"2026-08-27 11:00","pubTimestamp":1787799615,"startTime":"0","endTime":"0","summary":"Shares of IMMUNEONCO-B (01541) jumped nearly 12% during Tuesday trading, last up 10.41% at HK$4.085 with turnover reaching HK$3.429 million.The surge follows the company's interim results released on...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","PSYK","BMED","MDTX","IBBJ","VXUS","BK1161","KCAI","01541","BK4585","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1152821983","title":"IMMUNEONCO-B Reports Interim Results with RMB 25.4 Million Revenue and Key Clinical Trial Milestones","url":"https://stock-news.laohu8.com/highlight/detail?id=1152821983","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1152821983?lang=en_us&edition=fundamental","pubTime":"2026-08-26 21:56","pubTimestamp":1787752576,"startTime":"0","endTime":"0","summary":"IMMUNEONCO-B (01541) has released its interim results for the six months ended June 30, 2026, reporting revenue of RMB 25.424 million. Research and development expenses totaled RMB 155 million,...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PSYK","BK1161","MDTX","01541","IBBJ","BMED","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662708712","title":"ImmuneOnco FY26 Interim Revenue Falls 33.2% to RMB 25.4 Million; R&D Expenses Drop 7.9% to RMB 154.8 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2662708712","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662708712?lang=en_us&edition=fundamental","pubTime":"2026-08-26 21:41","pubTimestamp":1787751717,"startTime":"0","endTime":"0","summary":"ImmuneOnco FY26 interim revenue falls 33.2% to RMB 25.4 million; R&D expenses drop 7.9% to RMB 154.8 millionImmuneOnco posted revenue of RMB 25.4 million for the six months ended June 30, 2026, down 3","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nNDL2N6WK0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01541","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1118698746","title":"ImmuneOnco reaches two clinical milestones for IMC-003: first PAH patient dosed and Phase I enrolment completed","url":"https://stock-news.laohu8.com/highlight/detail?id=1118698746","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1118698746?lang=en_us&edition=fundamental","pubTime":"2026-08-25 18:47","pubTimestamp":1787654850,"startTime":"0","endTime":"0","summary":"ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (IMMUNEONCO-B, 01541) has reported two key advances for its independently developed activin receptor type IIA-Fc fusion protein, IMC-003/IMM72. The...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01541"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1192850803","title":"IMMUNEONCO-B (01541) Achieves Two Key Clinical Milestones in IMC-003 Development, Including First PAH Patient Dosed","url":"https://stock-news.laohu8.com/highlight/detail?id=1192850803","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1192850803?lang=en_us&edition=fundamental","pubTime":"2026-08-25 18:44","pubTimestamp":1787654653,"startTime":"0","endTime":"0","summary":"IMMUNEONCO-B (01541) has announced two significant clinical milestones for IMC-003/IMM72, a proprietary ActRIIA-Fc fusion protein developed by its subsidiary, Immuncare Biopharmaceutical Technology...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IMC","BK1161","BK4168","01541"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662735417","title":"ImmuneOnco Says First PAH Patient Dosed in Phase Ib/IIa Trial of IMC-003","url":"https://stock-news.laohu8.com/highlight/detail?id=2662735417","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662735417?lang=en_us&edition=fundamental","pubTime":"2026-08-25 18:37","pubTimestamp":1787654273,"startTime":"0","endTime":"0","summary":"ImmuneOnco says first PAH patient dosed in Phase Ib/IIa trial of IMC-003ImmuneOnco Biopharmaceuticals (Shanghai) dosed the first patient in a Phase Ib/IIa pulmonary arterial hypertension trial of IMC-","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260825:nNDL71fHZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01541","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1119750546","title":"ImmuneOnco secures FDA IND clearance for Phase Ib/II study of dual-targeting antibody IMM0306 in systemic lupus erythematosus","url":"https://stock-news.laohu8.com/highlight/detail?id=1119750546","media":"Bulletin Express","labels":["productRelease","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1119750546?lang=en_us&edition=fundamental","pubTime":"2026-08-21 20:45","pubTimestamp":1787316325,"startTime":"0","endTime":"0","summary":"Hong Kong-listed ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (IMMUNEONCO-B, 01541) reported that the U.S. Food and Drug Administration has cleared the Investigational New Drug application for...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01541"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661260429","title":"ImmuneOnco Wins FDA IND Clearance for Imm0306 Lupus Phase Ib/II Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2661260429","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661260429?lang=en_us&edition=fundamental","pubTime":"2026-08-21 20:07","pubTimestamp":1787314025,"startTime":"0","endTime":"0","summary":"ImmuneOnco wins FDA IND clearance for IMM0306 lupus Phase Ib/II trialFDA cleared an IND for ImmuneOnco’s IMM0306, enabling a Phase Ib/II trial in systemic lupus erythematosus.IMM0306 is a CD47/CD20 bi","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260821:nNDL5c90g0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01541","BK1161"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":1,"totalSize":111,"code":"91000000","status":"200"}]}}